Czech National Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
22,453
+706
+3% +$396K 0.06% 251
2026
Q1
$12.2M Buy
21,747
+691
+3% +$443K 0.08% 224
2025
Q4
$14.2M Buy
21,056
+736
+4% +$501K 0.09% 191
2025
Q3
$13M Buy
20,320
+663
+3% +$402K 0.09% 202
2025
Q2
$10.5M Buy
19,657
+850
+5% +$406K 0.08% 219
2025
Q1
$7.9M Buy
18,807
+1,052
+6% +$457K 0.07% 247
2024
Q4
$7.34M Buy
17,755
+989
+6% +$434K 0.07% 252
2024
Q3
$8.47M Buy
16,766
+1,028
+7% +$499K 0.09% 218
2024
Q2
$7.67M Buy
15,738
+1,125
+8% +$565K 0.09% 207
2024
Q1
$7.89M Buy
14,613
+60
+0.4% +$32.8K 0.1% 195
2023
Q4
$8.08M Buy
14,553
+45
+0.3% +$21.1K 0.12% 178
2023
Q3
$6.34M Buy
14,508
+4,682
+48% +$2.33M 0.1% 205
2023
Q2
$4.93M Buy
9,826
+70
+0.7% +$33.5K 0.11% 179
2023
Q1
$4.88M Buy
9,756
+62
+0.6% +$29.7K 0.12% 177
2022
Q4
$3.95M Buy
9,694
+19
+0.2% +$7.38K 0.11% 218
2022
Q3
$3.15M Buy
+9,675
New +$3.55M 0.09% 242

Other funds holding IDXX

Czech National Bank's IDXX Position: Q2 2026 in Review

Czech National Bank increased its Idexx Laboratories (IDXX) stake by 3.2% in Q2 2026, buying an estimated $396K and bringing the position to 22,453 shares worth $11.8M. The position accounts for 0.06% of the portfolio, ranked #251.

Czech National Bank first reported a position in IDXX in Q3 2022 and has held it in 16 quarters since. The position peaked at $14.2M in Q4 2025. 408 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Czech National Bank held 22,453 shares of Idexx Laboratories worth $11.8M as of Q2 2026.
  • Czech National Bank bought 706 Idexx Laboratories shares in Q2 2026, an estimated $396K.
  • Idexx Laboratories made up 0.06% of Czech National Bank's portfolio in Q2 2026, its #251 holding.
  • Czech National Bank first reported a position in Idexx Laboratories in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Idexx Laboratories position peaked at $14.2M in Q4 2025.
  • 408 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.